Elsevier Biomarkers for Cancer Screening, Diagnosis and Targeted Therapeutic Approaches (Volume 170) (Advances in Cancer Research, Volume 170)

Biomarkers for Cancer Screening, Diagnosis and Targeted Therapeutic Approaches, Volume 170 provides an integrated overview of the current state and future directions of biomarker research in oncology. The book bridges fundamental molecular insights with clinical applications, emphasizing how biomarkers are transforming cancer detection, diagnosis, prognosis, and personalized treatment strategies. Chapters cover an Introduction to cancer biomarkers and current research, Role of Biomarkers for cancer detection, diagnosis, and treatment, Classification of Cancer Biomarkers based on treatment strategies, Predictive, Prognosis and Diagnostic Cancer Biomarker in cancer therapeutic approaches, Biomarkers for targeted therapy and treatment decision-making, and much more. Additional sections delve in to Emerging trends in cancer biomarker and their clinical effect on personalized treatment, Recent advances in detection techniques regarding predictive, prognostic and diagnostic biomarkers in solid cancers and its future challenges, Recent advances in detection techniques regarding predictive, prognostic and diagnostic biomarkers in body fluids and its future challenges, Emerging biomarkers for non-invasive cancer diagnosis and treatment, and more. The brings together recent advancements in molecular diagnostics, predictive and prognostic markers, and targeted therapeutic development across a wide range of cancer types. Bridges fundamental research on cancer biomarkers and their clinical applications Provides a unified understanding on how molecular mechanisms translate into diagnostic and therapeutic outcomes Focuses on precision and targeted oncology, highlighting emerging predictive, prognostic, and diagnostic biomarkers that support personalized treatment strategies and guide therapeutic decision-making for improved patient outcomes Emphasizes emerging technologies and future directions, showcasing recent advancements in biomarker detection techniques, non-invasive diagnostic tools, and future perspectives that address current limitations and inspire innovative research in cancer biomarker discovery